mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.04 |
mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.04 |
mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.05 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.05 |
mRNA |
ZG-10 |
GDSC1000 |
pan-cancer |
AAC |
-0.09 |
0.05 |
mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
-0.07 |
0.05 |
mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
-0.071 |
0.05 |
mRNA |
BRD-K97651142 |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.05 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.05 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.05 |